Revolution Medicines, Inc. (NASDAQ:RVMD)

About the company

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

95

CEO

Mark A. Goldsmith

Exchange

NASDAQ

Website

http://www.revmed.com

$48.00M

Total Revenue

95

Employees

$2B

Market Capitalization

-25.41

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$-64M

Net Margin (in %)

Total net margin

$-70M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 11623.49 2872.00 5.84 111.44 3.63
Perrigo Co. Plc PRGO 7558.29 4837.00 1.30 51.56 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 5049.92 1443.00 1.75 9.75 36.59
MyoKardia, Inc. MYOK 4271.56 34.00 12.41 -13.78 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2231.84 9.00 2.62 -3.45 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1520.98 285.00 3.60 7.87 66.41
Intercept Pharmaceuticals, Inc. ICPT 1442.88 272.00 -42.94 -4.21 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1232.34 88.00 -8.65 -4.99 -280.80
Zogenix, Inc. ZGNX 1225.80 5.00 3.35 -2.88 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 784.32 3014.00 -1.07 -2.80 -9.09
BellRing Brands, Inc. BRBR 762.45 954.00 -0.41 5.78 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 613.18 79.00 4.86 -3.03 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Catalyst Pharmaceuticals, Inc. CPRX 528.58 119.00 5.15 12.05 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 388.24 130.00 5.55 -52.75 -5.01
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
ANI Pharmaceuticals, Inc. ANIP 326.76 203.00 1.67 -209.46 -0.67
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 147.85 None 2.41 -7.16 None
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Evoke Pharma, Inc. EVOK 83.28 None 28.92 -12.39 None
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Cassava Sciences, Inc. SAVA 63.46 41.00 3.34 -13.92 76.71
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
SCYNEXIS, Inc. SCYX 48.28 0.00 10.14 -1.25 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.56 0.00 -2.45 -2.70 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 17.22 0.00 1.52 -0.80 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.15 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.48 None 1.12 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Revolution Medicines Announces Proposed Public Offering of Common Stock

6d ago, source: YAHOO!

Revolution Medicines, Inc. (Nasdaq:RVMD) today announced that it has commenced an underwritten public offering of 5,500,000 shares of.

Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock

4d ago, source: MarketWatch

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD) today announced the pricing of its underwritten public offering of 6,000,000 shares of common stock at ...

Revolution Stumbles on Stock Offering

5d ago, source: Middle East North Africa Financial Network

(MENAFN - Baystreet.ca) Revolution Medicines Inc (NASDAQ:RVMD) reported a 5.5-million-share common stock offering Tuesday. The Redwood City, Calif.-based company goes on to say all of the shares of ...

BRIEF-Revolution Medicines Files For Offering Of Up To 5.5 Mln Shares Of Common Stock

6d ago, source: Reuters

REVOLUTION MEDICINES INC FILES FOR OFFERING OF UP TO 5.5 MILLION SHARES OF COMMON STOCK - SEC FILING Source text: [bit.ly/3f6HjWC] Further company coverage: (Reuters.Briefs@thomsonreuters.com) Our ...

Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor

20d ago, source: MarketWatch

REDWOOD CITY, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer ...

Biotech's surge pushes Bay Area companies — including a Covid drug hopeful — toward collective $1 billion in fresh funds

6d ago, source: The Business Journals

From cancer to Covid, Bay Area biotechs in line for 3 IPOs and four follow-on offerings that could raise more than $1 billion ...

Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors

25d ago, source: YAHOO!

REDWOOD CITY, Calif., June 18, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.